ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 280 filers reported holding ICU MED INC in Q4 2020. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $693,114 | -32.3% | 5,824 | +1.4% | 0.01% | -25.0% |
| Q2 2023 | $1,023,702 | +5.1% | 5,745 | -2.7% | 0.01% | -11.1% |
| Q1 2023 | $974,254 | +7.9% | 5,906 | +3.0% | 0.01% | 0.0% |
| Q4 2022 | $902,675 | +8.6% | 5,732 | +3.8% | 0.01% | 0.0% |
| Q3 2022 | $831,000 | -7.8% | 5,520 | +0.7% | 0.01% | 0.0% |
| Q2 2022 | $901,000 | -25.8% | 5,479 | +0.5% | 0.01% | -10.0% |
| Q1 2022 | $1,214,000 | -5.7% | 5,454 | +0.6% | 0.01% | 0.0% |
| Q4 2021 | $1,287,000 | +0.5% | 5,423 | -1.2% | 0.01% | 0.0% |
| Q3 2021 | $1,281,000 | +14.5% | 5,491 | +1.0% | 0.01% | +11.1% |
| Q2 2021 | $1,119,000 | -6.1% | 5,438 | -6.3% | 0.01% | -10.0% |
| Q1 2021 | $1,192,000 | -3.6% | 5,802 | +0.6% | 0.01% | -9.1% |
| Q4 2020 | $1,237,000 | +13.4% | 5,768 | -3.4% | 0.01% | 0.0% |
| Q3 2020 | $1,091,000 | +33.5% | 5,971 | +34.7% | 0.01% | -8.3% |
| Q2 2020 | $817,000 | -12.2% | 4,433 | -3.9% | 0.01% | -25.0% |
| Q1 2020 | $930,000 | -54.4% | 4,611 | -57.7% | 0.02% | -36.0% |
| Q4 2019 | $2,040,000 | +6.7% | 10,902 | -9.0% | 0.02% | +8.7% |
| Q3 2019 | $1,912,000 | -37.4% | 11,978 | -1.2% | 0.02% | -34.3% |
| Q2 2019 | $3,053,000 | +7.0% | 12,119 | +1.6% | 0.04% | +2.9% |
| Q1 2019 | $2,854,000 | +4.4% | 11,923 | +0.1% | 0.03% | -2.9% |
| Q4 2018 | $2,735,000 | -17.8% | 11,912 | +1.2% | 0.04% | +12.9% |
| Q3 2018 | $3,329,000 | +7.1% | 11,772 | +11.3% | 0.03% | 0.0% |
| Q2 2018 | $3,107,000 | +20.7% | 10,579 | +3.7% | 0.03% | +19.2% |
| Q1 2018 | $2,574,000 | -53.0% | 10,200 | -59.8% | 0.03% | -50.9% |
| Q4 2017 | $5,481,000 | +279.3% | 25,377 | +226.4% | 0.05% | +211.8% |
| Q3 2017 | $1,445,000 | +6.4% | 7,774 | -1.3% | 0.02% | -10.5% |
| Q2 2017 | $1,358,000 | +14.4% | 7,874 | +1.3% | 0.02% | +11.8% |
| Q1 2017 | $1,187,000 | +6.5% | 7,774 | +2.8% | 0.02% | +6.2% |
| Q4 2016 | $1,115,000 | +18.2% | 7,564 | +1.3% | 0.02% | +14.3% |
| Q3 2016 | $943,000 | +10.6% | 7,464 | -1.3% | 0.01% | +16.7% |
| Q2 2016 | $853,000 | +11.2% | 7,564 | +2.7% | 0.01% | +20.0% |
| Q1 2016 | $767,000 | -5.1% | 7,364 | +2.8% | 0.01% | -9.1% |
| Q4 2015 | $808,000 | +9.0% | 7,164 | +5.9% | 0.01% | +10.0% |
| Q3 2015 | $741,000 | -4.1% | 6,764 | -28.4% | 0.01% | +11.1% |
| Q4 2014 | $773,000 | +28.8% | 9,450 | +1.1% | 0.01% | +28.6% |
| Q3 2014 | $600,000 | +0.3% | 9,350 | -5.1% | 0.01% | 0.0% |
| Q2 2014 | $598,000 | +3.6% | 9,850 | +2.1% | 0.01% | 0.0% |
| Q1 2014 | $577,000 | -13.2% | 9,650 | -7.7% | 0.01% | -12.5% |
| Q4 2013 | $665,000 | -16.7% | 10,450 | -11.1% | 0.01% | -20.0% |
| Q3 2013 | $798,000 | -4.1% | 11,750 | +1.7% | 0.01% | -9.1% |
| Q2 2013 | $832,000 | +25.5% | 11,550 | +2.7% | 0.01% | +22.2% |
| Q1 2013 | $663,000 | – | 11,250 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVR Research LP | 22,000 | $4,719,000 | 3.86% |
| NUANCE INVESTMENTS, LLC | 901,483 | $193,359,000 | 3.73% |
| Nitorum Capital, L.P. | 417,241 | $89,494,000 | 3.46% |
| Tamarack Advisers, LP | 73,000 | $15,452,000 | 3.22% |
| PFM Health Sciences, LP | 267,817 | $57,444,000 | 2.02% |
| KIRR MARBACH & CO LLC /IN/ | 22,222 | $4,766,000 | 1.49% |
| PURA VIDA INVESTMENTS, LLC | 174,399 | $37,407,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,584 | $554,000 | 0.88% |
| Findlay Park Partners LLP | 528,825 | $113,428,000 | 0.79% |
| Altium Capital Management LP | 9,321 | $1,999,000 | 0.75% |